(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.72%) $83.25
(-1.16%) $1.619
(-0.14%) $2 343.80
(-0.18%) $27.49
(0.40%) $925.80
(-0.11%) $0.934
(-0.12%) $11.01
(-0.17%) $0.799
(0.00%) $92.17
0.00% HKD 0.750
Live Chart Being Loaded With Signals
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally...
Stats | |
---|---|
Dagens volum | 70 000.00 |
Gjennomsnittsvolum | 47 466.00 |
Markedsverdi | 296.29M |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.0191 ( 2017-05-31 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -2.78 |
ATR14 | HKD0 (0.00%) |
PuraPharm Corp Ltd Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
PuraPharm Corp Ltd Økonomi
Annual | 2023 |
Omsetning: | HKD406.86M |
Bruttogevinst: | HKD214.85M (52.81 %) |
EPS: | HKD-0.270 |
FY | 2023 |
Omsetning: | HKD406.86M |
Bruttogevinst: | HKD214.85M (52.81 %) |
EPS: | HKD-0.270 |
FY | 2022 |
Omsetning: | HKD448.07M |
Bruttogevinst: | HKD260.59M (58.16 %) |
EPS: | HKD-0.300 |
FY | 2021 |
Omsetning: | HKD659.59M |
Bruttogevinst: | HKD423.35M (64.18 %) |
EPS: | HKD-0.329 |
Financial Reports:
No articles found.
PuraPharm Corp Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.0840 | 2016-05-19 |
Last Dividend | HKD0.0191 | 2017-05-31 |
Next Dividend | HKD0 | N/A |
Payout Date | 2017-06-23 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD0.103 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.73 | -- |
Div. Sustainability Score | 0.0346 | |
Div.Growth Potential Score | 1.386 | |
Div. Directional Score | 0.710 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3888.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
1755.HK | Ex Dividend Knight | 2023-07-03 | Annually | 0 | 0.00% | |
0798.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
2338.HK | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
1313.HK | Ex Dividend Junior | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
0373.HK | Ex Dividend Junior | 2023-05-04 | Semi-Annually | 0 | 0.00% | |
6178.HK | Ex Dividend Junior | 2023-07-12 | Annually | 0 | 0.00% | |
1869.HK | Ex Dividend Junior | 2023-05-25 | Sporadic | 0 | 0.00% | |
0896.HK | Ex Dividend Junior | 2023-07-05 | Semi-Annually | 0 | 0.00% | |
0034.HK | Ex Dividend Knight | 2023-12-15 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.261 | 1.500 | -5.21 | -7.82 | [0 - 0.5] |
returnOnAssetsTTM | -0.126 | 1.200 | -4.19 | -5.03 | [0 - 0.3] |
returnOnEquityTTM | -0.574 | 1.500 | -7.49 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.612 | 0.800 | -1.939 | -1.552 | [1 - 3] |
quickRatioTTM | 0.225 | 0.800 | -3.38 | -2.70 | [0.8 - 2.5] |
cashRatioTTM | 0.0827 | 1.500 | -0.652 | -0.978 | [0.2 - 2] |
debtRatioTTM | 0.478 | -1.500 | 2.04 | -3.06 | [0 - 0.6] |
interestCoverageTTM | -1.798 | 1.000 | -1.777 | -1.777 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.137 | 2.00 | 9.95 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0818 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.63 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.528 | 1.000 | 4.53 | 4.53 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.121 | 1.000 | -4.42 | -4.42 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.134 | 1.000 | -0.367 | -0.367 | [0.2 - 2] |
assetTurnoverTTM | 0.482 | 0.800 | -0.119 | -0.0956 | [0.5 - 2] |
Total Score | 0.0346 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -2.79 | 1.000 | -0.383 | 0 | [1 - 100] |
returnOnEquityTTM | -0.574 | 2.50 | -4.81 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0818 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.137 | 2.00 | 9.95 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00604 | 1.500 | -3.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.133 | 1.000 | 9.18 | 0 | [0.1 - 0.5] |
Total Score | 1.386 |
PuraPharm Corp Ltd
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.